Clinical Trial Detail

NCT ID NCT04499053
Title Durvalumab in Combination With Chemotherapy in Virus-infected Patients With Non-small Cell Lung Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Georgetown University
Indications

lung non-small cell carcinoma

Therapies

Carboplatin + Durvalumab + Paclitaxel

Carboplatin + Durvalumab + Nab-paclitaxel

Cisplatin + Durvalumab + Pemetrexed Disodium

Carboplatin + Durvalumab + Pemetrexed Disodium

Age Groups: senior adult

Additional content available in CKB BOOST